ADCs are a new wave of antibody based products and consist of monoclonal antibodies attached to a cytotoxic drug via a linker, thus combining the cell targeting of the monoclonal antibody with the cell killing ability of the cytotoxic drug.

BioPharmaSpec has a strong reputation for the comprehensive characterization of a wide range of ADCs, including Lysine and Cysteine linked conjugates. We can fully characterize the structural and physicochemical attributes of the monoclonal antibody as follows:

Structural Characterization

Physicochemical Characterization

In addition to the above, BioPharmaSpec has methods for assessing: